Profile
Dr. John D.
Yee, MD, is a Senior Vice President-Medical Affairs at Apnimed, Inc. He is on the Board of Directors at Tempest Therapeutics, Inc. and Comera Life Sciences, Inc. Dr. Yee was previously employed as an Independent Director by Comera Life Sciences Holdings, Inc., a Chief Medical Officer by Sobi, Inc., a Senior Vice President-Medical Affairs by Flexion Therapeutics, Inc., a Senior VP & Head-Medical Affairs by Vertex Pharmaceuticals, Inc., a Vice President-Global Medical Affairs by Intarcia Therapeutics, Inc., and a Vice President & Head-Medical Affairs by Genzyme Corp.
He received his undergraduate degree from Harvard College, a graduate degree from Harvard T.H.
Chan School of Public Health and a doctorate degree from Harvard Medical School.
John Yee active positions
| Companies | Position | Start |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Director/Board Member | 04/06/2026 |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Director/Board Member | - |
Apnimed, Inc.
Apnimed, Inc. BiotechnologyHealth Technology Engages in discovering of novel pharmacologic therapies for sleep apnea and related disorders | Chief Tech/Sci/R&D Officer | 01/09/2023 |
Former positions of John Yee
| Companies | Position | End |
|---|---|---|
| COMERA LIFE SCIENCES HOLDINGS, INC. | Director/Board Member | 03/01/2023 |
Sobi, Inc.
Sobi, Inc. Medical DistributorsDistribution Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
| FLEXION THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 01/01/2019 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Chief Tech/Sci/R&D Officer | 01/01/2017 |
Training of John Yee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apnimed, Inc.
Apnimed, Inc. BiotechnologyHealth Technology Engages in discovering of novel pharmacologic therapies for sleep apnea and related disorders | Health Technology |
Sobi, Inc.
Sobi, Inc. Medical DistributorsDistribution Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Distribution Services |
Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Health Technology |
Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
- Stock Market
- Insiders
- John Yee
















